INTRODUCTION
As one of the leading zoonotic foodborne pathogens worldwide [
1],
Salmonella, a Gram-negative, facultative anaerobic bacillus belonging to the Enterobacteriaceae family within the order Enterobacter [
2], exhibits broad host tropism across livestock species, including swine, chickens, and ducks, causing acute gastroenteritis, septicemia, and systemic typhoidal disease [
3]. Annually,
Salmonella infection accounts for approximately 93.8 million cases of gastroenteritis worldwide, leading to an estimated 155,000 fatalities. In Korea, 544 cases of confirmed gastroenteritis outbreaks were reported in 2017 [
4]. In neonatal and juvenile animals,
Salmonella infection often leads to high morbidity and mortality, imposing substantial economic burdens on the livestock industry. Critically, certain serovars undergo vertical transmission in avian breeding flocks [
5], enabling the persistent colonization of reproductive tracts and subsequent egg contamination. Once established in a production facility, such infections are notoriously difficult to eradicate, posing persistent biosecurity risks not only to the affected farm but also to neighboring operations through environmental shedding and transmission via personnel or vehicles, thereby threatening the sustainability of regional livestock health [
6]. Meanwhile, the rising global demand for animal-derived foods, such as meat, eggs, and dairy, has increased human exposure to contaminated products [
7]. Through the food chain,
Salmonella can cause a range of clinical manifestations, from mild gastroenteritis to severe typhoid fever, enteric fever, and even sepsis, seriously endangering the security of public health [
8]. According to data on the global burden of disease data from the World Health Organization (WHO), there were 95.2 million new cases of
Salmonella infection in 2017, with 50,771 associated deaths [
9].While current control strategies rely primarily on vaccination and antimicrobial therapy, both approaches face significant limitations. Licensed vaccines provide incomplete protection and fail to prevent asymptomatic carriage or environmental persistence [
10], while routine subtherapeutic antibiotic use in livestock disrupts commensal gut microbiota, impairs mucosal immunity, and exerts strong selective pressure that accelerates the emergence of multidrug-resistant and extensively drug-resistant
Salmonella strains [
11]. Therefore, there is an urgent need for novel, non-antibiotic intervention strategies that combine precise pathogen targeting, favorable safety profiles, and direct antimicrobial activity with host-directed immunomodulation and intestinal barrier stabilization to safeguard livestock gut health and advance the transition toward sustainable, antibiotic-free livestock production.
Salmonella infection triggers a robust host immune response characterized by the rapid generation of reactive oxygen species (ROS) in phagocytic cells, particularly in neutrophils and macrophages [
12]. At physiological concentrations, ROS act as critical antimicrobial effectors by inducing oxidative damage to bacterial DNA, proteins, and membranes, thereby playing an essential role in intracellular pathogen clearance [
13]. However, dysregulated or excessive ROS production causes collateral oxidative injury to host macromolecules, including nuclear and mitochondrial DNA, functional and structural proteins, and polyunsaturated membrane lipids, resulting in epithelial and immune cell dysfunction, disruption of the intestinal epithelial barrier, and amplification of mucosal inflammation [
14]. Mechanistically, elevated ROS levels promote the dissociation of thioredoxin-interacting protein (TXNIP) from reduced thioredoxin, freeing TXNIP to bind and activate the NLRP3 inflammasome, a central signaling complex that drives Caspase-1-dependent pyroptosis [
15]. Consequently, ROS serve as a redox-sensitive second messenger that functionally couples oxidative stress with inflammasome activation. While controlled pyroptosis facilitates
Salmonella containment via the lytic release of pro-inflammatory cytokines and danger-associated molecular patterns (DAMPs), a pathological hyperactivation of this pathway impairs macrophage viability, facilitates intracellular bacterial escape, promotes systemic dissemination, and worsens disease severity [
16]. Collectively, the concurrent suppression of
Salmonella-induced oxidative stress and NLRP3-mediated pyroptosis represents a mechanistically grounded and therapeutically promising strategy for alleviating intestinal inflammatory pathology.
Deer antlers, typically harvested once or twice annually, represent the only mammalian organ capable of complete, annual regeneration [
17]. Following their removal, wound healing at the pedicle proceeds rapidly with minimal intervention, which can include topical applications of plant-derived ash to achieve hemostasis, providing direct evidence for the presence of endogenous wound-healing factors within antler tissue [
18]. Notably, post-harvest infections are exceptionally rare in deer, suggesting that antler tissue may contain intrinsic antimicrobial agents. Because of this, deer antler peptides (DAPs) identified as the principal bioactive components of antlers, have attracted growing scientific interest. Accumulating evidence has indicated that DAPs exert diverse pharmacological effects, including immunomodulation [
19], anti-osteoporotic activity [
20], antitumor effects [
21], anti-inflammatory properties [
22], and a mitigation of oxidative stress [
23]. Although a prior study has explored the antibacterial activity of deer antler extracts against pathogenic microorganisms [
24], the specific molecular mechanisms underlying DAPs-mediated antibacterial action remain largely undefined. Accordingly, in this study, we investigate whether naturally derived DAPs alleviate
Salmonella-induced intestinal inflammation, oxidative stress, and pyroptosis, and we further elucidate the molecular mechanisms of this process.
MATERIALS AND METHODS
Bacterial culture and infection
Salmonella strain SL1344 (Cat#bio-110527; Biobw) was cultured in Luria–Bertani broth at 30°C. For cell infection assays, macrophages were pre-treated with DAPs for 12 h and subsequently infected with Salmonella at a multiplicity of infection (MOI) of 10 for 1 h.
Deer antler peptides extraction
DAPs were extracted under the supervision of Professor Zhen Liu (Qingdao Agricultural University). The extraction steps proceeded as follows: Fresh deer antler was washed with sterile normal saline to remove surface blood, fine velvet hair, and adherent debris, followed by brief disinfection with 75% (v/v) ethanol. The cleaned antler was then sliced into 0.5 cm thick sections to ensure consistent particle size during downstream processing. To prepare the tissue homogenates, the slices were immersed in cold normal saline (4°C) and mechanically disrupted using a high-speed tissue grinder until a homogeneous suspension was obtained. Ultrasonic disruption was subsequently performed on ice to further disrupt cellular membranes and enhance intracellular peptide release. Enzymatic hydrolysis was conducted in two sequential steps: first, neutral protease was added to the homogenate, and incubated at 37°C and pH 7.0 for 5 h; second, the pH was adjusted to 8.0, and alkaline protease and papain were added, followed by incubation at 55°C for 6 h. Enzyme inactivation was achieved by adjusting the pH to 9.0. The resulting digest was centrifuged at 5,000×g for 15 min at 4°C to pellet insoluble residues, and the supernatant was carefully collected. Finally, the supernatant was subjected to vacuum freeze-drying to yield a stable, bioactive DAPs powder. The final DAPs preparation exhibited a purity of 90.91%, satisfying the stringent purity criteria required for functional assays.
Peritoneal primary macrophage isolation and culture
C57BL/6 WT and nrf2−/− mice, aged 6–8 weeks, were intraperitoneally injected with 3 mL of sterile thioglycollate broth. Mice were housed under standard pathogen-free conditions for 72 h post-injection. Euthanasia was performed by cervical dislocation; immediately thereafter, the abdominal surface was disinfected with 75% (v/v) ethanol. The abdominal skin was incised, and the exposed peritoneal surface was thoroughly wiped with a 75% ethanol-soaked cotton swab. Subsequently, 5 mL of ice-cold normal saline was injected into the peritoneal cavity, and the abdomen was gently massaged for 1 min to facilitate cell detachment and suspension. Peritoneal lavage fluid was collected and centrifuged at 300×g for 5 min at 4°C, and the supernatant was carefully discarded. The resulting cell pellet was resuspended in complete primary macrophage culture medium. Cells were seeded into a culture dish and incubated at 37°C with 5% CO2 for 3 h to allow adherence. Non-adherent cells were removed by gentle washing with normal saline, and the adherent population was confirmed as primary peritoneal macrophages.
CCK-8 assay
Primary peritoneal macrophages were seeded into 96-well culture plates at a density of 1×105 cells/well and incubated overnight at 37°C in a humidified 5% CO2 incubator. The following day, the culture medium was replaced with fresh complete macrophage medium supplemented with serially diluted DAPs at final concentrations of 0, 5, 10, 15, 20, 25, 30, 35, 40, and 50 mg/mL. The cells were exposed for 12 h, with six biological replicates per concentration. Thereafter, 10 μL of CCK-8 reagent (Solarbio) was added to each well, and plates were incubated for an additional 30 min under the same conditions (37°C, 5% CO2). Absorbance at 450 nm was measured using a microplate reader, following the manufacturer’s protocol.
Quantitative reverse transcription polymerase chain reaction
Total RNA was extracted from cultured cells and colonic tissues using a commercial RNA extraction kit (Yeasen), in accordance with the manufacturer’s protocol. RNA concentration and purity were assessed using a NanoDrop (Thermo Fisher Scientific), and cDNA synthesis was performed using 1 μg of total RNA and a commercial reverse transcription kit (Yeasen). Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was conducted using SYBR Green Master Mix (Yeasen) on a Bio-Rad Real-Time PCR Detection System. Reactions were carried out under the following cycling conditions: initial denaturation at 95°C for 5 min, followed by 40 cycles of 95°C for 10 s and 60°C for 30 s. All primer sequences were synthesized by Sangon Biotech and are listed below: TNF-α, F: 5′-TAGCCCACGTCGTAGCAAAC-3′, R: 5′-TGTCTTTGAGATCCATGCCGT-3′; IL-6, F: 5′-GGGACTGATGCTGGTGACAA-3′, R: 5′-ACAGGTCTG TTGGGAGTGGT-3′; GAPDH, F: 5′-GGGGTCGTTG ATGGCAACA-3′, R: 5′-AGGTCGGTGTGAACGGA TTTG-3′. Relative mRNA expression levels were calculated using the 2ΔΔCt method, with GAPDH serving as the endogenous reference gene for normalization.
Enzyme-linked immunosorbent assay
Cell culture supernatants from macrophages and homogenates of colonic tissue were prepared in ice-cold RIPA lysis buffer. Standard curves were generated using serial dilutions of recombinant cytokine standards. To prepare these, 100 μL aliquots of samples or diluted standards were added to pre-coated 96-well plates and incubated at 37°C for 90 min. Plates were washed three times with phosphate-buffered saline (PBS). Subsequently, 100 μL of biotinylated detection antibody was added to each well and incubated at 37°C for 50 min. After additional PBS washes, 100 μL of horseradish peroxidase (HRP)-conjugated streptavidin was added, and plates were incubated for 50 min at 37°C. Thereafter, 90 μL of TMB substrate solution was added to each well, and plates were incubated in the dark at 37°C for 20 min. The enzymatic reaction was terminated by adding 50 μL of stop solution. Optical density (OD) was measured at 450 nm using a microplate reader, and cytokine concentrations were interpolated from the respective standard curves. Enzyme-linked immunosorbent assay (ELISA) kits for TNF-α, IL-6, IL-1β and IL-18 were obtained from ELK Biotechnology.
Western blot
Nuclear protein extraction was performed using the Ultra Nuclear Protein Extraction Kit (Solarbio, Cat#: EX1471) following the manufacturer’s protocol. Briefly, upon completion of Salmonella infection, cell suspensions were centrifuged at 500×g for 5 min at 4°C, the supernatant culture medium was carefully aspirated, and cell pellets were collected. To achieve nuclear cytoplasmic fractionation, 2×106 cells were resuspended in 200 μL of ice-cold Reagent A, gently pipetted to achieve homogeneous mixing, and incubated with constant shaking for 20 min at 4°C, after which the mixture was centrifuged at 13,000×g for 5 min at 4°C, and the resulting supernatant was harvested as the cytoplasmic protein fraction. The remaining crude nuclear pellet was resuspended in PBS and centrifuged at 5,000×g for 5 min at 4°C; the supernatant was discarded to remove residual cytoplasmic contaminants, and the purified nuclear pellet was then resuspended in 100 μL of ice-cold Reagent B, vigorously vortexed for 15 s, and incubated with shaking for 30 min at 4°C. Finally, the mixture was centrifuged at 12,000×g for 10 min at 4°C, and the resulting supernatant was collected as the nuclear protein fraction.
Cells or colonic tissues were homogenized in ice-cold RIPA lysis buffer containing 1 mM PMSF (Solarbio) and a 1% protease and phosphatase inhibitor cocktail (Solarbio). Total protein concentration was quantified using the BCA Protein Assay Kit (Thermo Fisher Scientific) following the manufacturer’s protocol. Equal amounts of protein lysate were subjected to SDS-PAGE on 10% polyacrylamide gels and subsequently electrotransferred onto PVDF membranes. Membranes were blocked for 2 h at room temperature with 5% (w/v) non-fat milk in TBST, followed by overnight incubation at 4°C with primary antibodies against COX-2 (ABclonal), NRF2 (ABclonal), HO-1 (ABclonal), NQO1 (Zenbio), p-ERK (Zenbio), ERK (Zenbio), p-JNK (ABclonal), JNK (ABclonal), p-p38 (ABclonal), p38 (ABclonal), NLRP3 (Zenbio), GSDMD-NT (ABclonal), Caspase-1 (Zenbio), and β-actin (Zenbio). After washes with TBST, membranes were incubated with HRP-conjugated secondary antibody (Zenbio) for 1 h at room temperature. Immunoreactive bands were visualized using enhanced chemiluminescence (ECL) detection reagent (Yeasen) and captured with a chemiluminescence imaging system.
Hoechst/reactive oxygen species staining
Primary peritoneal macrophages were seeded into 12-well plates at a density of 1×106 cells per well. Following adherence for 4–6 h under standard culture conditions (37°C, 5% CO2), cells were pre-treated with DAPs for 12 h. Subsequently, macrophages were infected with Salmonella (SL1344) at a MOI of 10 for 1 h. After infection, extracellular bacteria were removed by gentle washing with ice-cold PBS. Cells were then incubated in serum-free DMEM containing 10 μM DCFH-DA (Yeasen) and 5 μg/mL Hoechst 33342 (Yeasen) for 30 min at 37°C in the dark. Unincorporated fluorescent probes were removed through two additional washes with ice-cold PBS, and cellular fluorescence was visualized using a fluorescence microscope.
Hoechst/propidium iodide staining
Primary peritoneal macrophages were seeded into 24-well plates at a density of 5×105 cells per well. Following adherence for 4–6 h under standard culture conditions (37°C, 5% CO2), the cells were pre-treated with DAPs for 12 h, and subsequently infected with Salmonella at an MOI of 10 for 1 h. Extracellular bacteria were removed through gentle washing with ice-cold PBS. The cells were then incubated in serum-free DMEM containing 5 μg/mL Hoechst 33342 (Yeasen) and 5 μg/mL propidium iodide (PI) (Yeasen) for 30 min at 37°C in the dark. Unbound fluorescent dyes were removed by washing with ice-cold PBS, and cells were observed and imaged using a fluorescence microscope.
Malondialdehyde/glutathione/superoxide dismutase measurement
Primary peritoneal macrophages (5×106 cells per well) were seeded into 6-well plates. Following adherence for 4–6 h under standard culture conditions (37°C, 5% CO2), cells were pre-treated with DAPs for 12 h and subsequently challenged with Salmonella at an MOI of 10 for 1 h. Extracellular bacteria were removed through gentle washing with ice-cold PBS. Cells were harvested on ice using cold PBS, lysed by sonication, and centrifuged at 12,000×g for 15 min at 4°C to obtain supernatants. The content of malondialdehyde (MDA) (Solarbio) and glutathione (GSH) (Solarbio), as well as superoxide dismutase (SOD) (Solarbio) activity, were quantified using respective commercial assay kits according to the manufacturers’ instructions.
Mouse model
Male C57BL/6 WT and NRF2 knockout (nrf2−/−) mice, aged 6–8 weeks, were purchased from Jiangsu Cyagen. Mice were housed in a specific pathogen-free facility at Guangdong Ocean University under controlled conditions, with a temperature of 22°C–23°C and a 12-h light/dark cycle. Standard rodent chow and autoclaved tap water were provided ad libitum. This study included 6 groups: WT control, WT–Salmonella, WT–Salmonella+DAPs, nrf2−/− control, nrf2−/−–Salmonella, and nrf2−/−–Salmonella+DAPs. Each group included 8–10 C57BL/6 mice. The Salmonella+DAPs groups received 50 mg/kg DAPs (dissolved in normal saline) via daily intragastric gavage for 7 consecutive days, while the control groups received an equivalent volume of normal saline. Next, the Salmonella and Salmonella+DAPs groups received 20 mg streptomycin in drinking water to suppress intestinal commensal microbiota; 24 h later, they were orally inoculated with 1×107 CFU of Salmonella SL1344 per mouse. Mice were humanely euthanized 72 h post-infection, and colonic tissues were collected for downstream molecular and histopathological analyses.
Histological analysis and disease activity index
Tissue sections were stained with hematoxylin and eosin (H&E) using an H&E Stain Kit (Solarbio), according to the manufacturer’s protocols. Briefly, paraffin-embedded sections were dewaxed in xylene and rehydrated stepwise through a graded ethanol series. Sections were stained with hematoxylin for 2 min, differentiated in 1% hydrochloric acid-ethanol for 5–10 s until nuclear chromatin exhibited clear blue staining, rinsed thoroughly with distilled water, and incubated in 1% ammonium hydroxide for 30 s to enhance blue contrast. Following counterstaining with eosin for 1 min, sections were dehydrated through a reverse graded ethanol series and sealed with neutral balsam. Histological images were observed and imaged using a microscope. Histological scores were assessed based on two parameters: epithelial damage and inflammatory cell infiltration. Epithelial damage scoring was as follows: 0 = normal morphology; 1 = focal goblet cell loss; 2 = extensive goblet cell loss; 3 = focal crypt loss; 4 = extensive crypt loss. Inflammatory cell infiltration was measured as follows: 0 = no infiltration; 1 = infiltration limited to crypt bases; 2 = infiltration extending to the muscularis mucosa; 3 = extensive infiltration of the muscularis mucosa with marked edema; 4 = infiltration spreading to the submucosa. Disease activity index (DAI) scores were assessed based on three parameters: weight loss, stool consistency, and fecal blood. Weight loss scoring was as follows: 0 = no weight loss; 1 = 1%–5% weight loss; 2 = 6%–10% weight loss; 3 = 11%–18% weight loss; 4 = more than 18% weight loss. Stool consistency scoring was as follows: 0 = normal formed stool; 1 = soft but formed stool; 2 = soft, loose stool; 3 = extremely soft, watery stool; 4 = watery diarrhea. Fecal blood was measured as follows: 0 = no visible blood; 1 and 2 = focal bloody feces; 3 = trace blood in stool; 4 = severe rectal bleeding. All histopathological and DAI assessments were conducted by blinded observers, and the scoring criteria were adapted from a previously published study [
25].
Colony-forming units
Mouse colon tissues were harvested and immersed in streptomycin sulfate solution for 30 min. Next, tissues were retrieved, the surface residual solution was carefully removed via sterile absorbent paper, and individual tissue weights were recorded. Sterile normal saline was added at a standardized ratio of 1:3 (tissue weight: saline volume) to each sample, and tissue homogenates were prepared via mechanical disruption. Homogenates were then serially diluted to generate 10–3 and 10–4 dilution gradients, with aliquots of each dilution evenly spread onto duplicate SS selective agar plates. Plates were incubated at 37°C under aerobic conditions overnight, and CFUs were enumerated 12 h post-incubation. The final results are presented as CFU/mg of colon tissue.
Immunohistochemical staining
Immunohistochemistry (IHC) was performed using a commercial IHC staining kit (Boster), following the manufacturer’s instructions. Briefly, sections were deparaffinized in xylene, rehydrated through graded ethanol, subjected to heat-induced antigen retrieval in 10 mM sodium citrate buffer via microwave heating (95°C for 15 min), and treated with 3% hydrogen peroxide for 15 min to quench endogenous peroxidase activity. Sections were blocked with 5% bovine serum albumin (BSA) in PBS for 1 h at room temperature, followed by overnight incubation at 4°C with primary antibody diluted in blocking buffer. The primary antibodies were MUC2 (Boster), ZO-1 (Boster), and Occludin (Boster). A biotinylated secondary antibody was applied for 1 h at room temperature. Immunoreactive signals were visualized using a 3,3′-diaminobenzidine (DAB) (Boster) substrate solution, terminated by rinsing in distilled water. Sections were counterstained with hematoxylin, differentiated in 1% hydrochloric acid-ethanol, blued in 1% ammonium hydroxide, dehydrated through ascending ethanol series, cleared in xylene, and permanently mounted with neutral balsam. Images were observed and imaged using a microscope.
Intestinal permeability
Mice were orally gavaged with FITC-dextran (molecular weight, 3–5 kDa, Sigma-Aldrich) at a dose of 0.6 mg/kg body weight, suspended diluted in sterile saline. Four hours post-gavage, blood was harvested and kept at room temperature for 30 min for clot formation. Serum was isolated through centrifugation at 1,500×g for 15 min at 4°C. FITC-dextran fluorescence concentration in serum was detected at an excitation of 485 nm and an emission of 528 nm using a microplate reader. Sample concentrations were determined in reference to a standard curve generated from serially diluted FITC-dextran in blank serum.
Statistical analysis
Statistical analyses were performed using GraphPad Prism 10.0, and data are presented as means±standard deviation. Multiple-group comparisons were assessed using one-way ANOVA, followed by Tukey’s multiple comparisons test, and differences were considered significant at * p<0.05, ** p<0.01, *** p<0.001 and **** p<0.0001; “ns” denotes not significant. All experiments were carried out at least three independent replicates. All in vitro experiments included at least three biologically independent replicates. Primary peritoneal macrophages were isolated from different mice at different time to eliminate shared biological or technical confounders. For in vivo experiments, each treatment group comprised 8–10 mice.
DISCUSSION
Salmonella infection represents one of the most prevalent and economically impactful bacterial enteric diseases in livestock and poultry production systems [
27]. The pathogen compromises intestinal epithelial barrier integrity, elicits robust pro-inflammatory responses, induces redox imbalance, and drives pyroptotic cell death, collectively impairing animal health, growth performance, and feed conversion efficiency [
28]. Against the backdrop of growing global concerns regarding antimicrobial resistance, residual antibiotic contaminants in animal-derived food products, and antibiotic-associated gut microbiota dysbiosis, there is an urgent imperative to identify safe, efficacious, and sustainable alternatives for the prevention and control of enteric infections. DAPs, bioactive peptides isolated through the enzymatic hydrolysis and purification of deer antler velvet, have demonstrated potent anti-inflammatory, antioxidant, and immunomodulatory properties across diverse preclinical models [
28]. Nevertheless, their efficacy against bacterial enteropathogens, particularly their capacity to mitigate
Salmonella-induced intestinal inflammation and the molecular mechanisms underlying this process remains largely unknown. In this study, we systematically evaluate the protective effects of DAPs against
Salmonella-induced intestinal injury using both
in vitro and
in vivo models, with mechanistic emphasis on the regulation of inflammatory signaling, pyroptosis, and oxidative stress.
DAPs exert potent anti-inflammatory effects through multiple coordinated mechanisms: these include the suppression of the pro-inflammatory enzymes COX-2 and 5-LOX; the downregulation of key cytokines TNF-α and IL-6 at both mRNA and protein levels; and the inhibition of central inflammatory signaling pathways, such as the MAPK signaling pathway, thereby attenuating the amplification and propagation of inflammatory cascades [
29]. Accordingly, we first evaluated the anti-inflammatory efficacy of DAPs in
Salmonella-infected murine macrophages. Consistent with prior reports, DAPs treatment significantly reduced TNF-α and IL-6 mRNA expression and protein secretion and suppressed the phosphorylation of ERK, JNK, and p38 signaling pathways, suggesting its functional modulation of canonical pro-inflammatory signaling axes. Notably, inflammation and pyroptosis are mechanistically interlinked: pathogen-associated molecular patterns, such as LPS prime NLRP3 inflammasome assembly, while GSDMD-mediated pore formation executes pyroptosis, facilitating the maturation and extracellular release of IL-1β and IL-18, along with DAMPs, thereby perpetuating secondary inflammatory responses [
30]. Given DAPs’ robust suppression of upstream inflammatory drivers, we hypothesized that they may concurrently inhibit pyroptotic cell death. Supporting this, DAPs markedly decreased pyroptosis in
Salmonella-infected macrophages. Collectively, these findings demonstrate that DAPs confer a dual inhibition of inflammation and pyroptosis in
Salmonella-challenged macrophages, highlighting their potential as a multi-target therapeutic agent for enteric bacterial infection.
NRF2, the master transcriptional regulator of cellular antioxidant defense and a pivotal modulator of inflammatory responses, serves as a central molecular target mediating the anti-inflammatory effects of DAPs [
31]. Accumulating evidence has demonstrated that DAPs activate the NRF2 signaling pathway, leading to a coordinated upregulation of downstream cytoprotective genes, including HO-1 and NQO-1, thereby restoring redox homeostasis and suppressing excessive inflammatory responses [
23]. These findings are consistent with the results of our study that DAPs treatment significantly suppressed oxidative stress in
Salmonella-infected macrophages predominantly through a canonical activation of the NRF2 pathway. Notably, in NRF2-deficient macrophages, DAPs completely failed to suppress
Salmonella-induced oxidative stress. Critically, in the absence of NRF2, DAPs failed to inhibit inflammatory responses and pyroptosis in
Salmonella-infected macrophages. Collectively, these findings demonstrate that DAPs confer integrated protection against
Salmonella-induced immunopathology by activating the NRF2 signaling axis to suppress MAPK-driven inflammatory signaling and NLRP3/Caspase-1/GSDMD-mediated pyroptosis. However, whether DAPs activate NRF2 through direct molecular engagement or indirectly via a modulation of upstream signaling pathways remains to be determined.
To further define the functional contribution of NRF2 to DAPs-mediated protection against
Salmonella–induced intestinal inflammatory injury, we established an acute colitis model in WT and
nrf2−/− mice via oral gavage with
Salmonella. Notably, DAPs reduced
Salmonella loads in the colonic tissues of both WT and
nrf2−/− mice. Crucially,
in vitro antimicrobial assays confirmed that DAPs had no direct bacteriostatic or bactericidal activity against
Salmonella, indicating that their
in vivo antibacterial effect may be associated with enhanced macrophage phagocytosis, upregulated antimicrobial peptides, or a modulated inflammatory microenvironment to restrict bacterial niche establishment and replication, though additional experiments are needed to confirm this. To date, no published studies have demonstrated that DAPs exert regulatory effects on the growth of pathogenic bacteria. In contrast, a single study has provided preliminary evidence that pilose antler polypeptides may modulate the composition of the intestinal microbiota [
22]. Further histopathological and molecular analyses revealed that DAPs significantly attenuated
Salmonella-induced colonic tissue inflammatory response in WT mice, but had no effects on
nrf2−/− mice, thereby establishing NRF2 as indispensable for DAPs’ anti-inflammatory and tissue-protective actions
in vivo. These findings are consistent with previous studies demonstrating that DAPs alleviate acetaminophen-induced oxidative stress and apoptosis by activating the NRF2/Keap1/HO-1 pathway [
32], and that DAPs exert neuroprotective effects in a Parkinson’s disease model through a modulation of oxidative damage via the AKT/NRF2/HO-1 axis [
33]. Moreover, DAPs robustly inhibited pyroptosis in the colonic tissues of
Salmonella-infected WT mice, but this anti-pyroptotic effect was not seen in
nrf2−/− mice. Similarly, DAPs effectively mitigated oxidative stress in WT colonic tissue, whereas they failed to normalize redox parameters in
nrf2−/− mice. This finding is consistent with a prior study demonstrating that sika deer antler protein mitigates acetaminophen-induced oxidative stress through an activation of the NRF2/Keap1/HO-1 signaling pathway [
32]. Collectively, our data identify NRF2 as a central and non-redundant signaling hub through which DAPs coordinately suppress oxidative stress, inflammation, and pyroptosis during
Salmonella-induced colitis. Intriguingly, although pyroptosis is conventionally regarded as host-protective, primarily by facilitating pathogen clearance, our results reveal a more nuanced paradigm: DAPs achieve potent antibacterial efficacy against
Salmonella despite suppressing pyroptosis, and this bactericidal effect is preserved in
nrf2−/− mice. These observations suggest that DAPs engage complementary, NRF2-independent immune regulatory mechanisms, such as the enhancement of macrophage phagocytic function or the potentiation of autophagy-mediated intracellular pathogen degradation to eliminate
Salmonella without a dependence on inflammatory cell lysis.
In this study, we have demonstrated that DAPs exert comprehensive protection of the intestinal epithelial barrier during
Salmonella infection predominantly through an activation of the NRF2 signaling pathway. Inflammation, oxidative stress, and pyroptosis are associated with increased intestinal paracellular permeability [
34].
Salmonella infection has been consistently demonstrated to increase intestinal permeability and compromise intestinal barrier integrity, whereas DAPs significantly attenuated
Salmonella-induced intestinal permeability in WT mice, as evidenced by the systemic levels of FITC-dextran, and preserved the expression of critical barrier effectors, including the secreted mucin MUC2, and the transmembrane tight junction proteins Claudin-1 and ZO-1. This finding is consistent with a prior study showing that DAPs significantly attenuate DSS-induced colonic inflammation in mice; suppress the secretion of pro-inflammatory cytokines TNF-α, IL-6, and IL-1β; and thereby maintains intestinal barrier integrity [
35]. However, all
in vivo experimental results were obtained exclusively in male mice; therefore, further studies including both sexes of mice are required to fully define the role of DAPs in
Salmonella infection.